Empowered Funds
EDIT icon

Empowered Funds’s Editas Medicine EDIT Stock Holding History

Empowered Funds’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$318K Buy
+123,882
New +$363K ﹤0.01% 2015

Other funds holding EDIT

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vivo Capital
Vivo Capital Palo Alto, California $909M AUM 385.65% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Empowered Funds's EDIT Position: Q3 2026 in Review

Empowered Funds opened a new position in Editas Medicine (EDIT) in Q3 2026: 123,882 shares worth $318K. The stake represents ﹤0.01% of the portfolio and ranks #2015 among its holdings.

162 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.

  • Empowered Funds held 123,882 shares of Editas Medicine worth $318K as of Q3 2026.
  • Editas Medicine was a new Empowered Funds position in Q3 2026.
  • Editas Medicine made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2015 holding.
  • 162 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.